Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 4 1Phase 2 1

Status

Completed 4Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 1

Conditions

Warts 1Uterine Cervical Dysplasia 1Papillomavirus Infections 1Infections 1Condylomata Acuminata 1Cancer Survivor 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 454Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Has results × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT05087849 2025-10-02

Intralesional HPV Vaccine for Condylomata

University of California, San Francisco

Phase 1/2 Completed
2 enrolled 7 charts

Condylomata Acuminata, Warts

NCT01824537 2025-03-19

TRAP-HPV

McGill University

Phase 4 Completed
372 enrolled 12 charts

Papillomavirus Infections

NCT05496231 2025-02-03

A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

GlaxoSmithKline

Phase 1/2 Completed
1,080 enrolled 28 charts
Gynecologic

Uterine Cervical Dysplasia, Infections

NCT01492582 2021-10-27

Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors

University of Alabama at Birmingham

Phase 2 Completed
1,499 enrolled 11 charts

Cancer Survivor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡